1,720 filings
6-K
AZN
Astrazeneca plc
25 Mar 24
Ultomiris Approved In the Us for Nmosd
7:28am
DFAN14A
FUSN
Fusion Pharmaceuticals Inc
19 Mar 24
Additional proxy materials by non-management
5:27pm
F-3ASR
AZN
Astrazeneca plc
19 Mar 24
Automatic shelf registration (foreign)
4:31pm
6-K
AZN
Astrazeneca plc
19 Mar 24
Current report (foreign)
6:02am
6-K
AZN
Astrazeneca plc
14 Mar 24
Astrazeneca to Acquire Amolyt
7:12am
6-K
9ozh 4wc01
12 Mar 24
Director/pdmr Shareholding
7:29am
6-K
sd6p5jicg5jntqk1t3l
7 Mar 24
Current report (foreign)
6:34am
6-K
nn96c9z3
7 Mar 24
Notice of Agm
6:30am
6-K
2dtkny3grj2d5 gl0
6 Mar 24
Director/pdmr Shareholding
10:11am
6-K
js8 y66hp
6 Mar 24
Director/pdmr Shareholding
10:06am
CERT
0125sm 2ucfuv
6 Mar 24
Certification of approval for exchange listing
7:21am
8-A12B
aozf nnbbl6km66c7
5 Mar 24
Registration of securities on exchange
4:40pm
6-K
gbaz4rhrlm7o
4 Mar 24
Ema Validates Dato-dxd Maas for NSQ NSCLC and BC
6:33am
6-K
wtljnzt9unzaq0u5p3
1 Mar 24
Total Voting Rights
10:39am
6-K
0wempb9h lcskvizmv
26 Feb 24
Current report (foreign)
4:05pm
6-K
pphcgo
26 Feb 24
Voydeya Recommended for Eu Approval
6:19am
424B2
hxh 7u95y71srd
23 Feb 24
Prospectus for primary offering
4:09pm
6-K
fnugamniy4zc
22 Feb 24
Astrazeneca Prices a $5BN Bond Offering
9:19am
6-K
8viombhp i9pr4ortd8
22 Feb 24
Current report (foreign)
9:14am
6-K
ybprphlpgb9 oz7rpn51
22 Feb 24
Director/pdmr Shareholding
6:08am